Sepsis remains a critical concern in clinical practice, accounting for significant morbidity and mortality worldwide. Timely and accurate identification of causative microorganisms is essential for guiding targeted therapy and improving patient outcomes. However, many laboratories still face challenges with delayed results, limited organism coverage, and workflow inefficiencies. The need for rapid, reliable diagnostic solutions is more urgent than ever, as clinicians and laboratorians strive to reduce broad-spectrum antibiotic use, shorten hospital stays, and enhance antimicrobial stewardship.
This webinar brings together three clinical laboratories to share their real-world experiences implementing MALDI-TOF mass spectrometry for direct identification of microorganisms from positive blood cultures. Presenters will describe their unique workflows, discuss the integration of FDA-cleared MALDI-TOF platforms, and highlight practical adaptations made to overcome operational barriers. Attendees will learn how these technologies can accelerate organism identification, expand coverage, and deliver measurable improvements in patient care and laboratory efficiency.
The session will feature case studies illustrating the impact of rapid identification on antimicrobial stewardship and patient outcomes, as well as tips for staff training, stakeholder engagement, and troubleshooting. Interactive polls and live Q&A will provide opportunities to address specific challenges faced by critical healthcare providers, including clinical laboratorians, laboratory managers, infectious disease physicians, and other professionals involved in sepsis management.
Register today to connect with leading experts and peers as they share practical advances in sepsis diagnostics. Whether you’re seeking to improve operational efficiency, strengthen antimicrobial stewardship, or stay informed about the latest diagnostic technologies, this webinar will provide valuable insights and real-world solutions. Join us virtually and be part of the conversation shaping the future of sepsis management.
Key Learning Objectives
- Explain the importance of rapid microorganism identification in the management of sepsis and its effect on patient outcomes.
- Describe the workflow and technical considerations for using mass spectrometry-based methods for direct identification from positive blood cultures.
- Compare mass spectrometry-based identification with molecular platforms, emphasizing complementary roles, cost-effectiveness, and real-world implementation experiences.
- Identify best practices for integrating rapid identification technologies into laboratory workflows, including overcoming barriers, optimizing antimicrobial stewardship, and improving resource utilization.
Only for sale in the USA and Puerto Rico.
